Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes

PURPOSE: A subset of patients with myelodysplastic syndromes (MDS) who are predicted to have lower-risk disease as defined by the International Prognostic Scoring System (IPSS) demonstrate more aggressive disease and shorter overall survival than expected. The identification of patients with greater...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Bejar, Rafael, Stevenson, Kristen E., Caughey, Bennett A., Abdel-Wahab, Omar, Steensma, David P., Galili, Naomi, Raza, Azra, Kantarjian, Hagop, Levine, Ross L., Neuberg, Donna, Garcia-Manero, Guillermo, Ebert, Benjamin L.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2012
Assuntos:
ORIGINAL REPORTS
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3438234/
https://ncbi.nlm.nih.gov/pubmed/22869879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.40.7379
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares